Our story
Egyhub for Pharmaceutical Industries started its journey in 2020, securing manufacturing contracts with premier pharmaceutical factories in Egypt and obtaining necessary approvals from regulatory bodies.
By the end of 2020, Egyhub for Pharmaceutical Industries decided to expand by establishing South Africa Pharma company to meet the market demands.
Early in 2021, market research was conducted to identify the demand for human and veterinary medications, guiding the selection and registration plan.
By 2022, regulatory approvals were secured from the NFSA and EDA.
In 2023, the way was paved for starting analysis and stability studies for veterinary products and establishing raw material stocks.
As of 2024, Egyhub for Pharmaceutical Industries proudly launches its products to meet market needs, ensuring a commitment to quality and innovation.
In May 2025, a strategic milestone was added to Egyhub for Pharmaceutical Industries' journey, as the Industrial Development Authority allocated land to Egyhub to construct its own manufacturing facility to meet the growing market demand for pharmaceuticals and dietary supplements while ensuring superior quality and compliance. The new factory will also allow Egyhub to integrate advanced pharmaceutical technologies into its production processes, marking a new era of innovation and growth.
Manufacturing Facilities
Egyhub for Pharmaceutical Industries’s commitment to quality and excellence is reflected in our Toll Manufacturing Department.
Presently, we collaborate with the best and most reputable factories in Egypt to ensure the production of our pharmaceuticals meets the highest standards, under the supervision of highly qualified Research and Development professionals.
This allows us to deliver premium dietary supplements and veterinary products to our customers, backed by certifications such as ISO 9001:2015 for Quality Management System, ISO 13485:2016 for Medical Devices Quality Management System, Good Manufacturing Practice (GMP) Certification, and other industry-specific certifications ensuring compliance with international standards and regulatory requirements.
With the upcoming factory construction, Egyhub is positioned to further enhance its manufacturing autonomy and scale.
Future Plans
Egyhub for Pharmaceutical Industries has strategic and ambitious plans that assure our commitment to global impact and growth.
Products Expansion by 2026: Egyhub for Pharmaceutical Industries is dedicated to expanding our products to address a more comprehensive range of pharmaceutical solutions.
Global Market Extension by 2026: Egyhub for Pharmaceutical Industries plans to make a significant mark internationally. To export our pharmaceutical solutions to the global market.
Launch of In-House Manufacturing Facility by 2027: Following the land allocation by the Industrial Development Authority in May 2025, Egyhub is on track to complete and launch its own factory by 2027.
This facility will enhance the company’s production capacity, support innovation through advanced manufacturing technologies, and ensure consistent quality to meet growing demand.
Quality Control Measures and Assurance Process
– Egyhub for Pharmaceutical Industries places a strong emphasis on ensuring the highest standards of quality across all aspects of its pharmaceutical and veterinary medication manufacturing processes.
– The company has implemented a comprehensive Quality Control (QC) and Quality Assurance (QA) framework to guarantee the safety, efficacy, and consistency of its products.
- The following highlights key elements of EgyHub for Pharmaceutical Industries's Quality Control and Assurance process:
- EgyHub for Pharmaceutical Industries operates modern and well-equipped manufacturing facilities, incorporating advanced technologies and adhering to industry best practices.
- Egyhub for Pharmaceutical Industries strictly adheres to international regulatory standards, including Good Manufacturing Practices (GMP), ensuring that its facilities and processes meet or exceed the requirements set forth by regulatory authorities.
- The company conducts precise assessments of raw materials used in the manufacturing of pharmaceuticals and veterinary medications. This includes thorough testing and validation to ensure the quality and purity of ingredients.
- Egyhub for Pharmaceutical Industries implements in-process quality checks throughout the manufacturing process to monitor critical parameters. This allows for real-time adjustments and ensures consistency in product quality.
- Egyhub for Pharmaceutical Industries employs advanced analytical techniques for testing and validating the identity, strength, purity, and stability of its products. This includes chromatography, spectroscopy, and other methods to assess product characteristics.
- Before products are released to the market, each batch undergoes a comprehensive review by the Quality Control team. Only batches meeting predefined specifications are released for distribution.
- Robust documentation and record-keeping systems are in place to track and trace every step of the manufacturing process. This ensures transparency, accountability, and facilitates audits and regulatory inspections.
- The company collaborates with reputable suppliers and implements stringent quality controls within its supply chain to guarantee the safety of raw materials and components.
- EgyHub for Pharmaceutical Industries actively engages in regulatory inspections and external audits to validate its adherence to international standards. This commitment reinforces confidence in the quality and safety of its products.
REGULATORY APPROVAL
Egyhub for Pharmaceutical Industries takes pride in its commitment to regulatory excellence, ensuring that all pharmaceutical and veterinary medication products adhere to the highest standards set by regulatory authorities.
The recognition and approval of our manufacturing processes by reputable regulatory bodies underscores our dedication to compliance.
Egyhub for Pharmaceutical Industries and its subsidiary, South Africa Pharma, have received formal approval from the Egyptian Drug Authority (EDA) for their manufacturing processes. This endorsement reflects our commitment to meeting and exceeding the regulatory requirements set by the national regulatory authority.
Egyhub for Pharmaceutical Industries ensures the sticking to Good Manufacturing Practices (GMP), to ensure the quality, safety, and efficacy of our pharmaceutical and veterinary products.
Regulatory approvals serve as a testament to our ongoing commitment to quality assurance. Egyhub for Pharmaceutical Industries prioritizes implementing stringent quality control measures at every stage of the manufacturing process.
Product licenses were obtained through HBS for Pharmaceutical Industries, a leading company specialized in regulatory affairs and pharmacovigilance. Our successful collaboration with HBS continues as we work together to complete the registration of the manufacturing site with the Egyptian National Food Safety Authority (NFSA) and secure its inclusion in the (White List), positioning the facility for future expansion and international market access.
Social Responsibility
At Egyhub for Pharmaceutical Industries, we are dedicated to making a positive impact on society through responsible business practices, which include:
- Ensuring access to our supplements and veterinary medications in all communities.
- Conducting health education for responsible product use in adults, children, and animals.
- Investing in eco-friendly practices, from sourcing to sustainable packaging.
- Actively engaging in local health events to strengthen community bonds.
- Supporting pediatric health and promoting responsible pet ownership.
- Fostering a workplace culture prioritizing employee well-being and development.
- Adhering to the highest standards of ethics, transparency, and accountability.
